Non-Inferiority Trial Comparing Eurofarma's Experimental Product Saccharomyces Boulardii Versus Floratil® in the Prevention of Antibiotic-Associated Diarrhea

NCT01463943 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2015-07-27

No results posted yet for this study

Summary

The study's objective is to evaluate the efficacy and safety of two formulations for the prophylactic treatment of diarrhea in subjects using antibiotics.

Conditions

  • Antibiotics

Interventions

OTHER

Probiotic

OTHER

Probiotic

OTHER

Probiotic

Sponsors & Collaborators

  • Eurofarma Laboratorios S.A.

    lead INDUSTRY

Principal Investigators

  • Carlos Fernando Francesconi, MD · Hospital Mãe de Deus

  • Flavio Quillici, MD · UNIGASTRO

  • Martti Antila, MD · Clínica de Alergia Martti Antila

  • Olavo Mion, MD · Hospital das Clínicas - SP

  • José Angelo Rizzo, MD · Universidade Federal de Pernambuco

  • Carlos Cezar Fritscher, MD · Hospital São Lucas da PUC - RS

  • Ronaldo Damião, MD · Hospital Universitario Pedro Ernesto

  • Flávio Steinwurtz, MD · Hospital Albert Einstein

  • Cyrla Zaltman, MD · Hospital Universitário Clementino Fraga Filho

  • José Hungria Neto, MD · Santa Casa de Misericórdia

  • Newton Carvalho, MD · Hospital de Clínicas da Universidade Federal do Paraná

  • Julio Cesar Teixeira, MD · University of Campinas, Brazil

  • Andreia Luisa Francisco Pez, MD · Pesquisare Saúde S/S Ltda

  • Paola Colares de Borba, MD · Instituto de Prevenção ao Câncer do Ceará

  • Cecília Roteli Martins, MD · HOSPITAL MATERNIDADE LEONOR MENDES DE BARROS

  • Paulo Sérgio Viero Naud, MD · Hospital das Clínicas de Porto Alegre

  • Bruno Gonçalves, MD · Hospital Leforte

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2012-11-30
Completion
2012-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01463943 on ClinicalTrials.gov